Lifestyle
- Regular exercise
- Adequate hydration
- Stress management
Serum Globulin · Gesamtglobulin
Globulin measures the total concentration of globulin proteins in the blood, which include alpha, beta, and gamma globulins.
Reference ranges can vary slightly based on laboratory standards.
Globulin is a group of proteins in the blood plasma that play critical roles in liver function, blood clotting, and fighting infections. It is one of the major protein fractions in the blood, along with albumin. Researchers have identified that globulins are involved in various biological processes including immune system regulation and transport of hormones and lipids. Clinically, globulin levels are important for diagnosing and monitoring liver disease, kidney disease, and immune disorders. Elevated globulin levels can indicate chronic inflammation, infections, or liver disease, while low levels may suggest kidney disease or malnutrition. In the context of athletic performance and biohacking, maintaining optimal globulin levels is crucial for immune function and recovery. Athletes might monitor globulin to ensure their immune system is not compromised due to intense training. However, factors such as dehydration, recent infections, or medications can confound globulin measurements. Time of day and fasting status generally do not significantly affect globulin levels, but it is recommended to follow consistent testing conditions for accurate monitoring.
Klinische Bedeutung
Elevated globulin levels may indicate chronic inflammatory diseases, infections, or liver disease. Low globulin levels can suggest kidney disease, liver dysfunction, or malnutrition.
Progressively rising globulin levels may suggest worsening chronic inflammation or liver disease. Retest in 4-6 weeks if elevated.
Falling globulin levels could indicate improving inflammation or nutritional status.
Re-test Interval
4 weeks if outside optimal range
Note:
Consult a healthcare provider before making significant dietary or lifestyle changes.
Testing Frequency
Annually for routine health check-ups, more frequently if monitoring specific conditions.
Correlated with
Current research suggests that the reference ranges for serum globulin levels, particularly in the context of conditions like polycystic ovary syndrome and upper tract urothelial carcinoma, remain debated, with optimal targets yet to be established. Researchers have not yet established the impact of confounding factors such as inflammation or liver function on globulin levels. Unanswered clinical questions include the role of globulin in predicting treatment responses and long-term outcomes in various diseases.
789
Total Citations
18
Human/RCT
3.4
Avg. Influence
2026
Latest
This review explored the role of sex hormone-binding globulin (SHBG) in polycystic ovary syndrome (PCOS). Researchers observed that lower SHBG levels correlate with increased androgen bioavailability, contributing to ovarian pathology and insulin resistance. The study suggests that SHBG may serve as a diagnostic biomarker and therapeutic target in managing PCOS.
This study investigated diagnostic methods for tuberculous pericarditis in 233 patients with pericardial effusions. Researchers found that serum globulin levels greater than 40 g/l were independently predictive of the disease. A diagnostic model incorporating pericardial fluid tests achieved high sensitivity and specificity, suggesting that basic clinical features can aid in diagnosis.
This review explored the clinical significance of sex hormone-binding globulin (SHBG) as a biomarker. Researchers found that SHBG levels are altered in various conditions, including hormonal disorders and certain cancers. The study discusses the potential of SHBG measurements as surrogate markers for disease assessment and management.
This article reviewed the clinical significance of corticosteroid-binding globulin (CBG) levels and genetic mutations. Researchers found that alterations in CBG levels may be associated with fatigue and immune defects. The study highlights the need for further research to clarify the implications of CBG mutations.
Researchers observed that genetic variants affecting serum SHBG levels are linked to metabolic syndrome and type 2 diabetes. They suggest that SHBG may play a direct role in the pathogenesis of these conditions. The findings support the development of therapies aimed at raising SHBG levels to prevent or treat related disorders.
Researchers noted that IgG subclass deficiency is associated with various clinical conditions, although its significance remains unclear. They suggest that gamma globulin therapy may benefit select patients with recurrent infections and subclass deficiency. The study highlights the need for further investigation into the clinical relevance of IgG subclasses.
This review focused on the challenges of diagnosing primary antibody deficiency (PAD). Researchers found that calculated globulin levels could serve as a screening tool to reduce diagnostic delays. The study emphasizes the need for integrating laboratory results with clinical data to improve early diagnosis of PAD.
Researchers observed that higher serum globulin levels (>3.8 g/dL) are associated with increased all-cause and infection-related mortality in hemodialysis patients. The study emphasizes the need to further investigate the mechanisms behind elevated globulin levels and their impact on patient outcomes.
This observational study explored the relationship between elevated serum globulin fraction and disease severity in inflammatory bowel disease (IBD). Researchers found that a high globulin fraction was independently associated with increased healthcare utilization and hospitalization rates. The findings suggest that globulin levels may serve as a biomarker for assessing disease severity in IBD patients.
This article examined autoimmune hepatitis and its recurrence post-liver transplantation. Researchers found that elevated serum globulin levels are characteristic of autoimmune hepatitis. The study underscores the importance of early diagnosis and treatment to prevent graft loss in affected patients.
3
Total Trials
124
Total Enrolled
University of Alberta
30
2025
Time normalized rate of infections grade 3 or greater
Cedars-Sinai Medical Center
60
2018
Percentage of Participants With Composite Efficacy Failure at 12 Months
Mayo Clinic
34
2009
Change in Proteinuria at 12 Months
Research publications about Globulin over time
8totalLog lab results, track trends and optimize your biomarkers over time.
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer